CIDRAP newsletters options
"We may see a substantial increase in this disease in the coming months to years."
US experts are closely watching the developments to see how the next months might unfold.
The risk of a range of neurologic conditions rose significantly in the year after COVID-19 infection among a group of US veterans—regardless of whether they had required hospitalization, according to a study published yesterday in Nature Medicine.
Swiss biopharmaceutical company Ferring Pharmaceuticals announced yesterday that the Food and Drug Administration's (FDA's) Vaccine and Related Biologic Products Advisory Committee (VRBPAC) voted in favor of the company's investigational fecal microbiota transplant (FMT)-based therapy.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Steady drops in new cases continue in North America and Europe, resulting in a 22% overall decline.
One study reveals signs of autoimmune disease in 41% of blood samples 1 year after recovery.
MRI reveals lung damage in children who either had COVID-19 up to a year earlier or have long COVID.
A studye suggests human, animal, and environmental exposures may all play a role.
The WHO says the outbreak location and its mobile population pose a risk of further spread.
A study in The Lancet Infectious Diseases demonstrates that previous Omicron BA.1 infection was the most protective factor against BA.2 infection (associated with a risk reduction of 72%) and gave greater protection than primary infection with pre-Omicron SARS-CoV-2 (38%) or three doses of an mRNA vaccine in people with no previous infection (46%).
Biopharmaceutical company Spero Therapeutics announced today that it has entered into a licensing agreement with GSK for the antibiotic tebipenem pivoxil hydrobromide (HBr).
"We are only beginning to understand the toll of the pandemic on HCW well-being."
After a 5-week drop, global COVID-19 cases stabilized last week, though deaths continued to decline, the WHO says.
A new report from Scotland's national health service shows that three key healthcare-associated infections remained stable or declined from 2020 to 2021.
The COVID-19 pandemic dramatically worsened disparities in all-cause death rates for American Indian and Alaska Native (AIAN), Native Hawaiian, other Pacific Islander (NHOPI), and Black Americans and eroded mortality advantages for Asian and Hispanic groups, finds a study published yesterday in PNAS.
Healthcare workers in lower-paying roles, however, were more likely to face unemployment.
The outbreak includes 1 confirmed fatal case and 8 suspected infections in people who are receiving medical care.
Multiple factors may be keeping these vulnerable populations from obtaining and using antibiotics appropriately.
Boston public schools (BPS) yesterday announced the first monkeypox case in an "adult member of the BPS community," according to a letter sent to parents. The school district said the person was isolating at home, and the district was working to identify exposed individuals.
